By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dicerna Pharmaceuticals 

480 Arsenal Street
Building 1, Suite 120
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-621-8097 Fax: n/a


Start Up

Company News
European Medicines Agency Grants Orphan Drug Designation To DCR-PH1, Dicerna (DRNA)'s Investigational Therapy For The Treatment Of Primary Hyperoxaluria Type 1 (PH1) 8/7/2015 9:04:55 AM
Dicerna (DRNA) Announces Second Quarter 2015 Financial And Operational Results 8/7/2015 8:05:16 AM
Dicerna (DRNA) To Announce Second Quarter 2015 Financial Results And Host Conference Call On August 6, 2015 7/30/2015 12:49:55 PM
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7/1/2015 11:42:03 AM
Dicerna (DRNA) To Present At The JMP Securities Life Sciences Conference 2015 6/19/2015 10:43:27 AM
Alnylam (ALNY) Slaps Dicerna (DRNA) With Trade Secret Lawsuit 6/11/2015 5:53:07 AM
ASCO15: Dicerna (DRNA) Presents Preliminary Safety And Efficacy Data From DCR-MYC Phase 1 Study In Patients With Advanced Solid Tumors At The 2015 ASCO Annual Meeting 6/2/2015 10:28:34 AM
Dicerna (DRNA) To Present At The Jefferies and Co. 2015 Healthcare Conference 6/1/2015 1:34:28 PM
Dicerna (DRNA) Announces Pricing Of Follow-On Offering Of Common Stock 5/21/2015 11:56:24 AM
Dicerna (DRNA) Announces Follow-On Public Offering Of Common Stock 5/19/2015 1:15:49 PM